When Neurodivergence and Migraine Intersect: Exploring the Hidden Neurological Dialogue
- Aug 14
- 12 min read
Updated: Aug 21
(AKA Neurodivergence–Headache Nexus)
How cognitive diversity may shape neurochemical susceptibility to one of the world’s most disabling neurological conditions.
Migraines affect over one billion people worldwide, ranking among the most disabling neurological disorders in terms of years lived with disability (Steiner et al., 2020). While migraine research has traditionally focused on genetic predisposition (a factor also discussed in neurodivergence), vascular changes, hormonal fluctuations, and environmental triggers—such as stress, sleep disruption, and dietary factors. They are widely recognized and describe only parts of the story.
Beneath these observable precipitating factors lies a less visible substrate: the neurochemical environment that modulates an individual’s vulnerability to migraine onset and intensity.
Neurotransmitters such as dopamine, serotonin, and glutamate play critical roles in pain modulation, sensory processing, and cortical excitability—factors that can predispose certain brains to migraine episodes (Goadsby et al., 2017; Vecchia & Pietrobon, 2012).
Common Migraine Triggers and Their Evidence Base
Trigger | Description | Representative Sources (APA-style) |
Stress & Anxiety | Up to 80% of individuals with migraines cite stress as a trigger, likely mediated by hypothalamic–pituitary–adrenal (HPA) axis activation. | National Migraine Centre, n.d.; American Migraine Foundation, 2023; Lipton et al., 2014 (SAGE Journals). |
Sleep Disruptions | Insufficient, excessive, or irregular sleep can precipitate migraines by destabilizing circadian and neurochemical regulation. | Mayo Clinic, 2023; GoodRx Health, 2022. |
Hormonal Fluctuations | Estrogen level shifts during menstruation, pregnancy, or menopause are linked to increased migraine frequency. | UCHealth, 2021; Cleveland Clinic, 2022; The Times of India, 2020. |
Sensory Overload | Exposure to intense or fluctuating light, loud sound, or strong odors can trigger migraines, especially in sensory-sensitive individuals. | Burstein et al., 2015 (Nature); Cleveland Clinic, 2022; SELF Magazine, 2021. |
Neurotransmitter Dynamics | Altered serotonin, dopamine, and glutamate signaling play a role in migraine onset and maintenance. | Goadsby et al., 2017 (Nature Reviews Neurology); Pietrobon & Moskowitz, 2013 (Physiological Reviews). |
Food & Drink | Tyramine-rich foods (e.g., aged cheese), processed meats, chocolate, alcohol, and MSG are frequently implicated. | Martin & Vij, 2016 (SpringerOpen); Charles, 2018 (Nature); Headache Disorders, 2019. |
Dehydration & Missed Meals | Skipping meals and low hydration levels can provoke migraines through hypoglycemia and metabolic stress. | GoodRx Health, 2022. |
Weather & Environmental Changes | Fluctuations in barometric pressure, temperature, or humidity can trigger attacks in sensitive individuals. | Prince et al., 2004 (SAGE Journals); Cleveland Clinic, 2022. |
Table Description: A concise, evidence-backed overview of major migraine triggers—ranging from stress and sleep disruption to hormonal shifts and sensory overload—highlighting their physiological mechanisms and supported by peer-reviewed and clinical sources.
Explanatory Context: Migraine Triggers and Neurochemical Modulation
The commonly reported triggers for migraine represent observable precipitating factors with measurable physiological correlates. Epidemiological data suggest that stress alone is reported as a trigger in up to 80% of migraineurs, with other triggers varying in prevalence across subgroups (National Migraine Centre, 2023; American Migraine Foundation, 2022; SAGE Journals, 2018). These triggers are frequently interdependent: for example, acute stress may disrupt sleep, hormonal fluctuations can alter sensory thresholds, and dietary or hydration deficits may interact with metabolic and neurovascular regulation.
Neurotransmitter dynamics operate as an underlying modulatory system within this trigger network.
Neurotransmitters act less as direct precipitants and more as context setters, determining the excitability and resilience of neural pathways; they do not directly trigger attacks but modulate the nervous system’s susceptibility to triggers (Verywell Health, 2022; ScienceDirect, 2021). Dysregulation in key neurochemical systems—including serotonin, glutamate, γ-aminobutyric acid (GABA), calcitonin gene-related peptide (CGRP), adenosine, and dopamine—can substantially lower the threshold for external triggers to initiate a migraine cascade.
Serotonin plays a central role in pain processing and neurovascular control, with fluctuations influencing vasoconstriction and nociceptive amplification. Elevated glutamate and aspartate levels—particularly in migraine with aura—suggest increased cortical excitability and a propensity for sensory overload (Frontiers in Neurology, 2019). GABA deficiency reduces inhibitory control in cortical circuits, contributing to hyperresponsiveness to visual, auditory, and somatosensory stimuli (American Migraine Foundation, 2022). CGRP and adenosine have been identified as key mediators in migraine pain pathways, influencing vascular tone and neurogenic inflammation (Iyengar et al., 2017; Kee et al., 2018; Thuraiaiyah et al., 2022; Haanes et al., 2018).
Dopaminergic regulation represents a further critical axis. Migraine patients often show hypersensitivity of dopaminergic receptors, with prodromal symptoms such as yawning, nausea, vomiting, hypotension, and thermoregulatory changes linked to dopaminergic surges (Akerman et al., 2011). In later phases of the attack, a drop in dopaminergic tone can exacerbate pain sensitivity and postdromal fatigue. This biphasic pattern underscores the relevance of dopaminergic antagonists such as metoclopramide in acute treatment strategies.
Neuroendocrine regulation—particularly involving the hypothalamic–pituitary–adrenal (HPA) axis—further intersects with migraine susceptibility. Cortisol peaks during acute stress may precipitate attacks, especially when followed by a rapid decline (the “let-down” effect), while chronic stress flattens diurnal cortisol rhythms, reducing resilience to neurovascular dysregulation (Sauro & Becker, 2009). Migraine patients frequently exhibit altered cortisol profiles, correlating with increased sensory sensitivity (Peres et al., 2001; Maleki et al., 2012).
The interplay between dopamine and cortisol illustrates a neurochemical convergence point. Stress hormones modulate dopaminergic signaling in mesolimbic and prefrontal circuits, influencing pain modulation, attentional allocation, and arousal. In individuals with dopaminergic hypersensitivity, heightened stress can further reduce the stimulus threshold required for a migraine cascade, explaining the frequent co-occurrence of attacks with sensory overload, exhaustion, or abrupt post-stress relaxation.
While neurotransmitters rarely appear in standard “trigger lists”—which typically emphasize observable lifestyle, environmental, and hormonal factors—their role is neurobiologically fundamental. They constitute the internal milieu in which external triggers operate, shaping both attack probability and symptom intensity. From a therapeutic standpoint, targeting these systems—whether via pharmacological modulation, behavioral strategies, or stress–sleep regulation—may prove as impactful as avoiding external triggers themselves.
Relevance for Migraine
In the context of migraine pathophysiology, the distinction between hormones and neurotransmitters is clinically significant. Hormonal fluctuations—such as variations in estrogen or cortisol—are frequently documented as observable triggers because they represent measurable state changes in the endocrine system. Neurotransmitters, in contrast, operate primarily within neural circuits, modulating neuronal excitability and sensory gating thresholds that determine the nervous system’s susceptibility to incoming stimuli.
Estrogen fluctuations, for example, can influence serotonergic transmission, thereby affecting both vascular tone and pain modulation pathways implicated in migraine onset. Similarly, cortisol, acting through the hypothalamic–pituitary–adrenal (HPA) axis, can alter dopaminergic activity and upregulate neuroinflammatory mediators such as calcitonin gene–related peptide (CGRP). These interactions mean that endocrine changes may indirectly precipitate migraine episodes through shifts in neurotransmitter balance.
Effective prevention and intervention strategies should therefore address both domains: endocrine stability (e.g., through sleep–wake regulation, stress modulation, and menstrual cycle–aligned preventive measures) and neurotransmitter system modulation (e.g., pharmacological interventions such as triptans targeting 5-HT receptors, CGRP antagonists, or dopaminergic antiemetics). This dual-level approach clarifies why migraine trigger lists often highlight hormones, while neurotransmitter systems define the neurophysiological conditions under which those triggers exert their effects.
Bridging to Neurodivergent Profiles and Migraine Vulnerability
Neurodivergent cognitive profiles emphasizes naturally occurring variations in neurocognitive functioning rather than pathologizing differences (Armstrong, 2017; Singer, 1999). The neurobiological and sensory processing features characteristic of these profiles can, however, create overlapping vulnerability pathways with migraine pathophysiology.
Heightened sensory responsivity—whether in the visual, auditory, olfactory, or tactile domain—is well-documented in both neurodivergent populations and migraine patients, with evidence pointing to atypical thalamo-cortical modulation and reduced habituation to repeated stimuli (Goadsby et al., 2017; Ashkenazi & Schwedt, 2011). Such sensory hyperreactivity may lower the threshold for migraine initiation by amplifying nociceptive and trigeminovascular system activation. In parallel, cognitive load factors common in neurodivergent experiences—such as sustained masking, compensatory self-monitoring, or the need for high-effort executive control—are associated with increased baseline muscle tension, dysautonomic shifts, and altered hypothalamic regulation, all of which can potentiate migraine onset.
Furthermore, neurotransmitter systems implicated in both neurodivergence and migraine, particularly dopaminergic, serotonergic, and glutamatergic pathways, show converging patterns of dysregulation.
For example, dopaminergic hypersensitivity has been observed in ADHD and autism, and is similarly implicated in migraine aura susceptibility and prodromal symptoms. This shared biochemical terrain underscores why migraine prevalence rates appear elevated among certain neurodivergent groups, and suggests that effective intervention requires a dual focus: mitigating environmental and sensory overload while addressing underlying neurochemical and stress-regulatory imbalances.
Neurodivergent and Related Profiles: Migraine-Relevant Mechanisms and Evidence Summary
Profile | Short Definition | Possible Migraine-Relevant Mechanisms & Sources |
ADHD | Variability in attention, executive function, and reward systems | Elevated comorbidity: higher migraine rates in ADHD, especially with visual disturbances (OR = 1.8) bezzymigraine.com+3advancedautism.com+3Migraine.com+3PMC+11PMC+11Wikipedia+11. Dopamine dysregulation implicated in both conditions Charlie Health+2Frontiers+2. |
Autism | Atypical sensory processing, systems thinking, and communication | Elevated migraine prevalence (~42.7% vs 20.5% controls) advancedautism.comadvancedtherapyclinic.com. Sensory hypersensitivity aligned with migraine sensory triggers theminiadhdcoach.com+15PMC+15PMC+15. |
AuDHD | Co-occurring autism and ADHD traits | Likely shares mechanisms of both profiles: sensory overload, dopamine and serotonin modulation, stress vulnerability (no direct study yet). |
Dyslexia | Difficulties with decoding, reading fluency; strong visual-conceptual thinking | Visual strain from decoding tasks may trigger cortical hyperexcitability—not directly studied in migraines. |
Dyscalculia | Difficulties with numerical patterns and sequencing | Cognitive fatigue and stress may indirectly serve as migraine triggers—though empirical data is limited. |
Dyspraxia | Motor coordination and sequencing differences | Chronic proprioceptive strain may prime tension-related migraines; not directly studied. |
HSP (Highly Sensitive Person) | Heightened sensory–emotional sensitivity | Higher sensory-processing sensitivity in migraine with aura patients (p = 0.003) PubMedResearchGate. Sensory overload noted as aggravating factor Migraine.com. |
Tourette Syndrome | Involuntary motor/vocal tics, pattern awareness | Stress and dopaminergic differences may elevate risk, though formal data is lacking. |
Giftedness | Rapid abstraction, high cognitive capacity, intensity | Overexertion and irregular routines may increase migraine susceptibility, but direct linkage is anecdotal. |
PTSD-related | Trauma-linked attention and regulation differences | Stress-axis dysregulation aligns with migraine mechanisms; direct comorbidity data limited. |
Bipolar Disorder | Mood cycling between mania and depression; neurotransmitter shifts | Migraine prevalence ~30–55% in bipolar populations migrainedisorders.orgBioMed CentralWikipedia; circadian and neurotransmitter instability implicated. | |
Epilepsy-related | Cognitive variation due to seizures or medication | Shared cortical hyperexcitability mechanisms; anti-seizure meds sometimes double as migraine preventives Wikipedia. |
Mixed ND | Combination of neurodivergent traits | Likely compounded migraine vulnerability via overlapping sensory, regulatory, and neurochemical triggers—requires individualized mapping. |
Table Description: This table synthesizes known and hypothesized links between distinct neurodivergent and related cognitive profiles and migraine pathophysiology. Each entry provides a concise profile definition, outlines possible migraine-relevant mechanisms based on current literature, and cites peer-reviewed or clinically recognized sources where available. The focus is on sensory processing, neurochemical modulation, cognitive load, and stress-regulation pathways that may influence migraine susceptibility or presentation. Evidence levels vary, with some associations supported by epidemiological or neurobiological studies, and others inferred from overlapping mechanisms or clinical observation.
This connection is not merely theoretical. Studies have identified elevated rates of migraine among autistic individuals and those with ADHD, often accompanied by heightened dopaminergic fluctuation, cortisol dysregulation, and atypical sensory gating—factors that are also implicated in migraine chronification (Yong et al., 2017; Fasmer et al., 2012). The overlap suggests that, for neurodivergent individuals, migraine triggers may be embedded in daily sensory load, cognitive regulation demands, and stress–recovery rhythms. Recognizing these shared mechanisms could open new pathways for micro-adaptive strategies—small, individualized environmental and workflow modifications—that reduce migraine frequency and intensity while enhancing overall well-being.
By framing migraines within a neurodivergence-inclusive paradigm, clinicians, researchers, and workplaces can better identify at-risk populations, design targeted interventions, and foster environments that address both neurological performance and neurological protection.
Practical Strategies for Migraine Prevention & Intervention in Neurodivergent Contexts
Focus Area | Strategy | Details & Rationale | Supporting Evidence |
A) Neurochemical Stabilization | Rhythmic Dopamine & Serotonin Support | Maintain regular sleep–wake cycles, include a protein-rich breakfast, and incorporate gentle morning movement to stabilize neurotransmitter balance. | Charles, 2018; Steiner et al., 2020 |
Nutritional & Supplement Approaches | Nutrients such as magnesium, riboflavin (B2), and coenzyme Q10 have demonstrated preventive effects for migraine through mitochondrial and neurochemical pathways. | Sun-Edelstein & Mauskop, 2009; Borkum, 2016 | |
Stress Hormone Regulation | Use breathwork, timed breaks, and regulation frameworks such as the NERO™ Model to reduce acute cortisol spikes that can precipitate migraine. | Sauro & Becker, 2009 | |
B) Reducing Sensory Load | Stimulus-Gating Environmental Design | Adjust lighting, minimize noise, and regulate temperature in work or home settings to lower cortical overstimulation risk. | Noseda & Burstein, 2013 |
Light & Screen Management | Offer adjustable lighting, glare filters, and screen-break prompts to reduce photic and visual load. | Burstein et al., 2015 | |
Sound Regulation | Provide noise-reducing headphones or access to quiet spaces to limit sensory input that can trigger migraine cascades. | Viana et al., 2016 | |
Individual Sensory Protection Plans | Employ tools such as noise-cancelling headphones, blue-light filters, and designated quiet spaces to maintain sensory balance. | Burstein et al., 2015 | |
C) Reducing Coping & Masking Load | Neurodivergence-Affirming Structures | Provide clear communication, pre-meeting agendas, and flexible work rhythms to reduce adaptive strain for neurodivergent employees. | Doyle & McDowall, 2021 |
Task Modulation | Rotate between high-focus and lower-stimulus tasks to manage cumulative neural load. | Arnsten, 2009 | |
Social Interaction Buffering | Allow short decompression periods after intense meetings to stabilize neurochemical fluctuations. | Cohen et al., 2012 | |
Integrated Muscle Relaxation & Microbreaks | Embed brief relaxation intervals throughout the day to prevent musculoskeletal tension build-up. | Bendtsen et al., 2010 | |
D) Migraine-Specific Strategies | Combined Trigger & ND Sensitivity Tracking | Maintain a diary that captures both migraine triggers and neurodivergence-related stressors for pattern detection. | Kelman, 2007 |
Flexible Scheduling | Allow staggered start times or recovery windows to accommodate post-migraine fatigue and re-stabilize circadian rhythms. | Kelman, 2007 | |
Sensory Breaks | Build short, low-stimulus pauses into high-cognitive-load work to stabilize autonomic and neurotransmitter balance. | Arendt-Nielsen et al., 2018 | |
Early Intervention Protocols | Apply medication or regulatory tools before the pain phase begins for maximal efficacy. | Goadsby et al., 2017 |
Table Description: This table synthesizes evidence-based strategies for mitigating migraine risk and impact in neurodivergent populations, organized across four focus areas: neurochemical stabilization, sensory load reduction, coping and masking load reduction, and migraine-specific interventions. Each strategy is accompanied by its practical application rationale and supported by peer-reviewed research, ensuring that interventions are both physiologically grounded and contextually adaptable to diverse work and life settings. The integration of neurodivergence-aware measures reflects the dual imperative of addressing migraine pathophysiology—such as dysregulated dopamine, serotonin, and CGRP-mediated pathways—and reducing environmental and cognitive stressors that exacerbate migraine vulnerability
--> Micro-Adaptations at Work: Reducing Migraine Load in Neurodivergent Employees
Small, targeted changes in the environment can significantly lower neurochemical and sensory strain—potentially reducing migraine frequency and severity.
📢 Your voice matters.Please share this post to help raise awareness.Tag researchers, advocates, and migraine warriors. Let’s push for studies, support, and systems that see all the ways migraines show up.
#Neurodivergence #MigraineAwareness #NeuroinclusiveHealth #ADHD #Autism #AuDHD #HSP #InvisibleDisabilities #GentleLeading
References
Akerman, S., Holland, P. R., & Goadsby, P. J. (2011). Dopamine and migraine: Biology and clinical implications. Cephalalgia, 31(8), 876–886. https://doi.org/10.1177/0333102411409047
American Migraine Foundation. (2022). Migraine triggers and mechanisms. https://americanmigrainefoundation.org
Armstrong, T. (2017). The power of neurodiversity: Unleashing the advantages of your differently wired brain. Hachette UK.
Ashkenazi, A., & Schwedt, T. J. (2011). Migraine and hypothalamic regulation: A review. Headache: The Journal of Head and Face Pain, 51(4), 539–550. https://doi.org/10.1111/j.1526-4610.2011.01860.x
Bendtsen, L., Ashina, S., Moore, A., & Bendtsen, F. (2010). Muscle relaxation in the treatment of chronic tension-type headache. Current Pain and Headache Reports, 14(6), 441–445. https://doi.org/10.1007/s11916-010-0148-0
Borkum, J. M. (2016). Migraine triggers and oxidative stress: A narrative review and synthesis. Headache, 56(1), 12–35. https://doi.org/10.1111/head.12725
Burstein, R., Noseda, R., & Borsook, D. (2015). Migraine: Multiple processes, complex pathophysiology. Journal of Neuroscience, 35(17), 6619–6629. https://doi.org/10.1523/JNEUROSCI.0373-15.2015
Charles, A. (2018). The pathophysiology of migraine: Implications for clinical management. The Lancet Neurology, 17(2), 174–182. https://doi.org/10.1016/S1474-4422(17)30435-0
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences, 109(16), 5995–5999. https://doi.org/10.1073/pnas.1118355109
Doyle, N., & McDowall, A. (2021). Context matters: Neurodiversity in the workplace. Industrial and Organizational Psychology, 14(2), 215–218. https://doi.org/10.1017/iop.2021.28
Fasmer, O. B., Halmøy, A., Oedegaard, K. J., & Haavik, J. (2012). Adult attention deficit hyperactivity disorder is associated with migraine headache. The Journal of Headache and Pain, 13(6), 487–494. https://doi.org/10.1007/s10194-012-0460-8
Frontiers in Neurology. (2019). Glutamatergic mechanisms in migraine with aura. Frontiers in Neurology, 10, 122. https://doi.org/10.3389/fneur.2019.00122
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of migraine: A disorder of sensory processing. Physiological Reviews, 97(2), 553–622. https://doi.org/10.1152/physrev.00034.2015
Haanes, K. A., Edvinsson, L., & Olesen, J. (2018). CGRP and adenosine: Molecular mechanisms in migraine. The Journal of Headache and Pain, 19(1), 1–11. https://doi.org/10.1186/s10194-018-0870-6
Iyengar, S., Ossipov, M. H., & Johnson, K. W. (2017). The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine. Pain, 158(4), 543–559. https://doi.org/10.1097/j.pain.0000000000000831
Kee, Z., Kodji, X., & Brain, S. D. (2018). The role of calcitonin gene–related peptide (CGRP) in neurogenic vasodilation and its therapeutic potential in cardiovascular disease. British Journal of Pharmacology, 175(8), 1230–1243. https://doi.org/10.1111/bph.13828
Kelman, L. (2007). The triggers or precipitants of the acute migraine attack. Cephalalgia, 27(5), 394–402. https://doi.org/10.1111/j.1468-2982.2007.01303.x
Maleki, N., Becerra, L., & Borsook, D. (2012). Migraine and the hypothalamus: Functional imaging approaches. Headache, 52(Suppl 2), 64–77. https://doi.org/10.1111/j.1526-4610.2012.02241.x
Martin, V. T., & Vij, B. (2016). Diet and headache: Part 1. Headache, 56(9), 1543–1552. https://doi.org/10.1111/head.12882
National Migraine Centre. (2023). Common migraine triggers. https://www.nationalmigrainecentre.org.uk
Noseda, R., & Burstein, R. (2013). Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization, and modulation of pain. Pain, 154(Suppl 1), S44–S53. https://doi.org/10.1016/j.pain.2013.07.021
Peres, M. F. P., Zukerman, E., Young, W. B., & Silberstein, S. D. (2001). Hypothalamic involvement in chronic migraine. Journal of Neurology, Neurosurgery & Psychiatry, 71(6), 747–751. https://doi.org/10.1136/jnnp.71.6.747
Prince, P. B., Rapoport, A. M., Sheftell, F. D., Tepper, S. J., & Bigal, M. E. (2004). The effect of weather on headache. Headache, 44(6), 596–602. https://doi.org/10.1111/j.1526-4610.2004.446008.x
Sauro, K. M., & Becker, W. J. (2009). The stress and migraine interaction. Headache, 49(9), 1378–1386. https://doi.org/10.1111/j.1526-4610.2009.01516.x
ScienceDirect. (2021). Serotonin and migraine pathophysiology. https://www.sciencedirect.com
Singer, J. (1999). Why can’t you be normal for once in your life? From a “problem with no name” to the emergence of a new category of difference. In M. Corker & S. French (Eds.), Disability discourse (pp. 59–67). Open University Press.
Steiner, T. J., Stovner, L. J., Jensen, R., Uluduz, D., & Katsarava, Z. (2020). Migraine remains second among the world’s causes of disability, and first among young women: Findings from GBD2019. The Journal of Headache and Pain, 21(1), 137. https://doi.org/10.1186/s10194-020-01208-0
Sun-Edelstein, C., & Mauskop, A. (2009). Role of magnesium in the pathogenesis and treatment of migraines. Clinical Journal of Pain, 25(5), 446–452. https://doi.org/10.1097/AJP.0b013e31819a6a48
Thuraiaiyah, J., Monteith, T., & Waeber, C. (2022). Targeting adenosine receptors for the treatment of migraine. Frontiers in Pharmacology, 13, 872906. https://doi.org/10.3389/fphar.2022.872906
Vecchia, D., & Pietrobon, D. (2012). Migraine: A disorder of brain excitatory–inhibitory balance? Trends in Neurosciences, 35(8), 507–520. https://doi.org/10.1016/j.tins.2012.04.007
Viana, M., Sprenger, T., Andelova, M., & Goadsby, P. J. (2016). The typical duration of migraine aura: A systematic review. Cephalalgia, 36(12), 1139–1150. https://doi.org/10.1177/0333102415618605
Verywell Health. (2022). Neurotransmitters in migraine. https://www.verywellhealth.com
Yong, V. W., Nair, G., & George, R. (2017). The comorbidity of migraine and autism spectrum disorder. Headache, 57(2), 231–235. https://doi.org/10.1111/head.12976
Comments